rW
|
Virus growth rate for wild-type in the absence of antibodies |
23.60 |
0–46 |
day
−1
|
Calculated (Appendix A) |
rM1
|
Virus growth rate for first mutant |
23.23 |
0–46 |
day
−1
|
Calculated (Appendix A) |
rM2
|
Virus growth rate for second mutant |
23.09 |
0–46 |
day
−1
|
Assumed |
K
|
Virus carrying capacity |
1.14 × 108
|
7.47 × 108–3.82 × 108 |
virus ml
−1
|
Calculated (Appendix A) |
pW
|
Wild-type virus neutralization by antibody |
1.462 × 10−2 × m
|
(1.21 × 10−2–2.67 × 10−2) × m
|
ml mg
−1 day−1
|
Calculated (Appendix A) |
pM1
|
Mutant 1 virus neutralization by antibody |
(varied) |
— |
ml mg
−1 day−1
|
Assumed |
pM2
|
Mutant 2 virus neutralization by antibody |
(varied) |
— |
ml mg
−1 day−1
|
Assumed |
q
|
Antibody decay rate |
0.0315 |
0.0277–0.0365 |
day
−1
|
[
32] |
ϵ1
|
Mutation rate from wild-type to first mutant (per base per cycle) |
2.7 × 10−5
|
1 × 10−5–3.4 × 10−5
|
day
−1
|
[
36] |
ϵ2
|
Mutation rate from wild-type to second mutant (per base per cycle) |
2.7 × 10−6
|
2 × 10−6–2.7 × 10−2
|
day
−1
|
Assumed |
Ai
|
Amount of antibody infusion |
38.4 × m
|
(25.6–51.2) × m
|
mg ml
−1
|
[
10
,
11
] |
A0
|
Antibody on Day 0 |
37.2 |
24.9–49.4 |
mg ml
−1
|
Calculated (Appendix A) |
VW(0) |
Number of wild-type viral particles that initiated infection |
224 |
175–350 |
virus ml−1
|
[
10,37] |
VM1(0) |
Number of Mutant 1 viral particles that initiated infection |
9 |
— |
virus ml−1
|
[
10] |
VM2(0) |
Number of Mutant 2 viral particles that initiated infection |
1 |
— |
virus ml−1
|
Assumed |
t1/2
|
Half-life of virus due to antibody neutralization |
1.3 |
0.7–1.8 |
day |
[
33–35] |
dW , dM1, dM2
|
Viral clearance rate |
23 |
9.1–36 |
day−1
|
[
38] |
m
|
Antibody magnification factor |
{1, 10, 50} |
— |
— |
— |